Clinical Scientist Beth Hoskins specialises in molecular genetics at GOSH. She analyses DNA tests from patients with rare conditions to test for abnormalities. When not at GOSH, Beth volunteers for GoodGym, a community of runners from all over the UK who work out while helping others.
She has clocked up 1,600 kilometres jogging around her borough carrying out 500 'good deeds', including running every week to see an isolated 64-year-old called Paul.
A new artificially intelligent bodysuit to help understand how mobility is affected in boys with Duchenne will be trialled in a collaboration between researchers at Great Ormond Street Hospital (GOSH) and Imperial College London.
A daily tablet has been shown to reduce the debilitating symptoms experienced by children with Multiple Sclerosis (MS) and cut the chance of relapse by 82%. There are currently no treatments specifically approved for adolescents with MS and this is the first time that an MS drug has been trialled specifically in young people.
Hundreds of children cared for at Great Ormond Street Hospital (GOSH) and their families were joined by celebrity friends and costumed characters to celebrate Christmas this week, at a magical festive party.
A new test to help diagnose and predict a range of serious childhood eye conditions has been developed by researchers at Great Ormond Street Hospital (GOSH) and the UCL Great Ormond Street Institute of Child Health (ICH).
Levels of myostatin, a protein that prevents muscle growth, could influence how well the body responds to anti-myostatin treatments for muscle-wasting conditions such as Duchenne Muscular Dystrophy (DMD). This breakthrough could help predict which patients will benefit from therapies that aim to increase muscle strength by blocking myostatin.